BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 22281166)

  • 1. The relationship between combination inhaled corticosteroid and long-acting β-agonist use and severe asthma exacerbations in a diverse population.
    Wells KE; Peterson EL; Ahmedani BK; Severson RK; Gleason-Comstock J; Williams LK
    J Allergy Clin Immunol; 2012 May; 129(5):1274-1279.e2. PubMed ID: 22281166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations.
    Gibson PG; Powell H; Ducharme FM
    J Allergy Clin Immunol; 2007 Feb; 119(2):344-50. PubMed ID: 17291852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.
    Chung KF; Caramori G; Adcock IM
    Eur J Clin Pharmacol; 2009 Sep; 65(9):853-71. PubMed ID: 19557399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.
    Eltonsy S; Forget A; Beauchesne MF; Blais L
    J Allergy Clin Immunol; 2015 Jan; 135(1):123-30. PubMed ID: 25226849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink.
    Ali AK; Hartzema AG; Winterstein AG; Segal R; Lu X; Hendeles L
    Value Health; 2015 Mar; 18(2):260-70. PubMed ID: 25773561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
    Ni CM; Greenstone IR; Ducharme FM
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children.
    Gibson PG; Powell H; Ducharme F
    Cochrane Database Syst Rev; 2005 Oct; 2005(4):CD005076. PubMed ID: 16235393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
    Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled Corticosteroid-Containing Treatment Escalation and Outcomes for Patients with Asthma in a U.S. Health Care Organization.
    Bengtson LGS; Yu Y; Wang W; Cao F; Hulbert EM; Wolbeck R; Elliott CA; Buikema AR
    J Manag Care Spec Pharm; 2017 Nov; 23(11):1149-1159. PubMed ID: 29083972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
    Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of ICS/LABA on Asthma Exacerbation Risk in Patients Within a Medical Group.
    Stanford RH; Nagar S; Lin X; O'Connor RD
    J Manag Care Spec Pharm; 2015 Nov; 21(11):1014-9. PubMed ID: 26521113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-five statements on early initiation of fixed combination ICS/LABA treatment for asthma and COPD in primary and secondary care: consensus research by a modified Delphi process.
    Kardos P; Bechtel B; Palovis L; Hagedorn C; Latif F
    Pneumologie; 2012 Sep; 66(9):549-57. PubMed ID: 22899206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.
    Main C; Shepherd J; Anderson R; Rogers G; Thompson-Coon J; Liu Z; Hartwell D; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(20):1-174, iii-iv. PubMed ID: 18485272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Step-Down Therapy for Asthma Well Controlled on Inhaled Corticosteroid and Long-Acting Beta-Agonist: A Randomized Clinical Trial.
    Rogers L; Sugar EA; Blake K; Castro M; Dimango E; Hanania NA; Happel KI; Peters SP; Reibman J; Saams J; Teague WG; Wise RA; Holbrook JT;
    J Allergy Clin Immunol Pract; 2018; 6(2):633-643.e1. PubMed ID: 28974349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
    Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
    Ducharme FM; Lasserson TJ; Cates CJ
    Cochrane Database Syst Rev; 2011 May; (5):CD003137. PubMed ID: 21563136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reasons and outcomes for patients receiving ICS/LABA agents prior to, and one month after, emergency department presentations for acute asthma.
    Villa-Roel C; Borgundvaag B; Majumdar SR; Emond M; Campbell S; Sivilotti M; Abu-Laban RB; Stiell IG; Aaron SD; Senthilselvan A; Rowe BH;
    J Asthma; 2019 Sep; 56(9):985-994. PubMed ID: 30311821
    [No Abstract]   [Full Text] [Related]  

  • 19. Serious Asthma Outcomes and Asthma Exacerbations with Maintenance on Inhaled Corticosteroid (Mometasone Furoate)/Long-Acting Beta Agonist (Formoterol) Combination Compared to Step Down to Mometasone Monotherapy.
    Weinstein CLJ; Ryan N; Zhang X; Shekar T; Gates D; Lane SJ; Agache I; Nathan RA;
    J Allergy Clin Immunol Pract; 2020 May; 8(5):1634-1644.e1. PubMed ID: 31981733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in asthma and COPD treatment: combination therapy with inhaled corticosteroids and long-acting beta 2-agonists.
    Miller-Larsson A; Selroos O
    Curr Pharm Des; 2006; 12(25):3261-79. PubMed ID: 17020533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.